Unveiling the role of TGF-β signaling pathway in breast cancer prognosis and immunotherapy
Our study developed a TSPRS, which emerges as a potent predictive instrument for the prognosis of breast cancer, offering novel perspectives on the immunotherapeutic approach to the disease.
Authors
- Rongxin Zhang (ORCID: https://orcid.org/0000-0002-4083-374X)
- Wenbin Huang (ORCID: https://orcid.org/0000-0001-9093-8091)
- Yanan Cao
- Wenqian Cai (ORCID: https://orcid.org/0000-0002-3876-1185)
- Li Li (ORCID: https://orcid.org/0000-0002-8630-3699)
- Lin Li (ORCID: https://orcid.org/0000-0001-6124-5237)
- Yifan Zheng (ORCID: https://orcid.org/0009-0000-5277-1702)
Institutions
- Guangdong Pharmaceutical University (CN)
- First Affiliated Hospital of Guangdong Pharmaceutical University (CN)
- Zhujiang Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-11-27
- DOI
- https://doi.org/10.3389/fonc.2024.1488137
- Citations
- 6
- Primary Topic
- Genetic factors in colorectal cancer
- Type
- article
- Field-Weighted Citation Impact
- 2.55